These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 37484213)

  • 1. Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis.
    Verma N; Divakar Reddy PV; Vig S; Angrup A; Biswal M; Valsan A; Garg P; Kaur P; Rathi S; De A; Premkumar M; Taneja S; Ray P; Duseja A; Singh V
    JHEP Rep; 2023 Aug; 5(8):100788. PubMed ID: 37484213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis.
    Prado V; Hernández-Tejero M; Mücke MM; Marco F; Gu W; Amoros A; Toapanta D; Reverter E; Peña-Ramirez C; Altenpeter L; Bassegoda O; Mezzano G; Aziz F; Juanola A; Rodríguez-Tajes S; Chamorro V; López D; Reyes M; Hogardt M; Kempf VAJ; Ferstl PG; Zeuzem S; Martínez JA; Vila J; Arroyo V; Trebicka J; Fernandez J
    J Hepatol; 2022 May; 76(5):1079-1089. PubMed ID: 35074475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Prevalence, Predictors, and Impact of Bacterial Infections to Guide Empiric Antimicrobial Decisions in Cirrhosis (EPIC-AD).
    Garg P; Verma N; Angrup A; Taneja N; Valsan A; Reddy VD; Agarwal J; Chaudhary R; Kaur P; Rathi S; De A; Premkumar M; Taneja S; Duseja A
    J Clin Exp Hepatol; 2024; 14(4):101352. PubMed ID: 38449507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying patients at high risk for multidrug-resistant organisms after hospitalization abroad.
    Bopp TC; Marchesi M; Zihlmann R; Sax H; Wolfensberger A
    Infect Control Hosp Epidemiol; 2023 Aug; 44(8):1281-1288. PubMed ID: 36912341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review.
    Cleland H; Tracy LM; Padiglione A; Stewardson AJ
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):82. PubMed ID: 35698209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis.
    Mücke MM; Hernández-Tejero M; Gu W; Kuhn M; Janz M; Keller MI; Fullam A; Altepeter L; Mücke VT; Finkelmeier F; Schwarzkopf KM; Cremonese C; Hunyady PM; Heilani MW; Uschner FE; Schierwagen R; Brol MJ; Fischer J; Klein S; Peiffer KH; Hogardt M; Shoaie S; Coenraad MJ; Bojunga J; Arroyo V; Zeuzem S; Kempf VAJ; Welsch C; Laleman W; Bork P; Fernandez J; Trebicka J;
    Aliment Pharmacol Ther; 2024 Apr; 59(7):877-888. PubMed ID: 38414095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota-associated risk factors for asymptomatic gut colonisation with multi-drug-resistant organisms in a Dutch nursing home.
    Ducarmon QR; Terveer EM; Nooij S; Bloem MN; Vendrik KEW; Caljouw MAA; Sanders IMJG; van Dorp SM; Wong MC; Zwittink RD; Kuijper EJ
    Genome Med; 2021 Apr; 13(1):54. PubMed ID: 33827686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonisation with multidrug-resistant organisms among dialysis patients at Universitas Academic Hospital.
    Shamhuyashe G; van Zyl N; van Rooyen C; Bisiwe F; Musoke J
    S Afr J Infect Dis; 2024; 39(1):607. PubMed ID: 39114261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
    Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V;
    J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors associated with multi-drug resistant organisms (MDRO) carriage among pediatric patients at the time of admission in a tertiary care hospital of a developing country. A cross-sectional study.
    Qureshi S; Maria N; Zeeshan M; Irfan S; Qamar FN
    BMC Infect Dis; 2021 Jun; 21(1):547. PubMed ID: 34107903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of carriage of multidrug-resistant bacteria in dogs and cats in veterinary care and co-carriage with their owners.
    Dazio V; Nigg A; Schmidt JS; Brilhante M; Campos-Madueno EI; Mauri N; Kuster SP; Brawand SG; Willi B; Endimiani A; Perreten V; Schuller S
    One Health; 2021 Dec; 13():100322. PubMed ID: 34522760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European hospitals as source of multidrug-resistant bacteria: analysis of travellers screened in Finland after hospitalization abroad.
    Kajova M; Khawaja T; Kantele A
    J Travel Med; 2022 Jul; 29(4):. PubMed ID: 35234907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Resistance in Organ Transplant Recipients.
    Giannella M; Rinaldi M; Viale P
    Infect Dis Clin North Am; 2023 Sep; 37(3):515-537. PubMed ID: 37244806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SHIELD Orange County Project: Multidrug-resistant Organism Prevalence in 21 Nursing Homes and Long-term Acute Care Facilities in Southern California.
    McKinnell JA; Singh RD; Miller LG; Kleinman K; Gussin G; He J; Saavedra R; Dutciuc TD; Estevez M; Chang J; Heim L; Yamaguchi S; Custodio H; Gohil SK; Park S; Tam S; Robinson PA; Tjoa T; Nguyen J; Evans KD; Bittencourt CE; Lee BY; Mueller LE; Bartsch SM; Jernigan JA; Slayton RB; Stone ND; Zahn M; Mor V; McConeghy K; Baier RR; Janssen L; O'Donnell K; Weinstein RA; Hayden MK; Coady MH; Bhattarai M; Peterson EM; Huang SS
    Clin Infect Dis; 2019 Oct; 69(9):1566-1573. PubMed ID: 30753383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, Risk Factors and Outcome Due to Multidrug Resistant Organisms in Paediatric Liver Transplant Patients in the Era of Antimicrobial Stewardship and Screening.
    Verma A; Vimalesvaran S; Dhawan A
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of American Thoracic Society guidelines in predicting infection or colonization with multidrug-resistant organisms in critically ill patients.
    Xie J; Ma X; Huang Y; Mo M; Guo F; Yang Y; Qiu H
    PLoS One; 2014; 9(3):e89687. PubMed ID: 24647408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis.
    Willems RPJ; van Dijk K; Vehreschild MJGT; Biehl LM; Ket JCF; Remmelzwaal S; Vandenbroucke-Grauls CMJE
    Lancet Infect Dis; 2023 Jun; 23(6):719-731. PubMed ID: 36731484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of tailored screening for multidrug-resistant organisms upon admission to an intensive care unit in the United Arab Emirates.
    Park S; Kim H; Gatchalian KK; Oh H
    Antimicrob Resist Infect Control; 2023 Nov; 12(1):135. PubMed ID: 38012753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteremia in Patients With Liver Cirrhosis: Prevalence and Predictors of Multidrug Resistant Organisms.
    Addo Smith JN; Yau R; Russo HP; Putney K; Restrepo A; Garey KW; Sofjan AK
    J Clin Gastroenterol; 2018 Aug; 52(7):648-654. PubMed ID: 29176351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit].
    Huang X; Li G; Yi L; Li M; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):667-71. PubMed ID: 26255016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.